FindTrial
Sign In

Pulmonary function and its clinical significance for pulmonary hypertension caused by fibrosing mediastinitis

Pulmonary function and its clinical significance for pulmonary hypertension caused by fibrosing mediastinitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072182
Enrollment
Unknown
Registered
2023-06-06
Start date
2023-06-06
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrosing mediastinitis complicated with pulmonary hypertension

Interventions

Case series:None

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
51 Years to 84 Years

Inclusion criteria

Inclusion criteria: (1) Include patients diagnosed with fibromediastinitis at Gansu Provincial People's Hospital from January 2014 to April 2023; (2) Patient has lung function test

Exclusion criteria

Exclusion criteria: 1. Patients with mediastinal malignancy 2. Patients with incomplete data (missing pulmonary function data)

Design outcomes

Primary

MeasureTime frame
Forced expiratory volume in one second;Diffusing capacity for carbon monoxide;Functional vital capacity;Mean pulmonary arterial pressure;Total lung capacity;Pulmonary vascular resistance;Cardiac index;—

Countries

China

Contacts

Public ContactYunshan Cao

Gansu Provincial Hospital

yunshancao@126.com+86 136 6930 6699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026